Evidence map›Paper›PMID 34626411›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2022

Generation of Drosophila Heparan Sulfate Mutant Cell Lines from Existing Fly Strains.

Eriko Nakato, Nanako Bowden, Hiroshi Nakato

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Eriko NakatoDepartment of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA.
Nanako BowdenDepartment of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA.
Hiroshi NakatoDepartment of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA. nakat003@umn.edu.
University of Minnesota · US

Funding

Heparan sulfate proteoglycans in signaling and developmentR35GM131688 · NIGMS · UNIVERSITY OF MINNESOTA · PI Hiroshi Nakato · 2019 to 2026
$2.6M
NIGMS NIH HHS R35 GM131688
6 · The paper itself

Abstract

Genetic studies using a model organism, Drosophila melanogaster, have been contributing to elucidating the in vivo functions of heparan sulfate proteoglycans (HSPGs). On the other hand, biochemical analysis of Drosophila glycosaminoglycans (GAGs) has been limited, mainly due to the insufficient amount of the material obtained from the animal. Recently, a novel in vitro system has been developed by establishing mutant cell lines for heparan sulfate (HS)-modifying enzyme genes. Metabolic radiolabeling of GAGs allows us to assess uncharacterized features of Drosophila GAGs and the effects of the mutations on HS structures and function. The novel in vitro system will provide us with a direct link between detailed structural information of Drosophila HS and a wealth of knowledge on biological phenotypic data obtained over the last two decades using this animal model.

Indexed as

Drosophila melanogasterAnimalsCell LineGlycosaminoglycansHeparan SulfateHeparan Sulfate ProteoglycansGlycosaminoglycansHeparan SulfateHeparan Sulfate ProteoglycansDecapentaplegicDrosophilaGAL4/UASHSMutant cell lines

Identifiers

PMID34626411
PMCPMC8930275
OpenAlexW3202723534

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.